Merz Pharma Drops Out Of Bidding War For Obagi Medical
German drugmaker Merz Pharma Group said Monday it has abandoned its bid for Obagi Medical Products Inc. after Valeant Pharmaceuticals International Inc. upped its offer to about $418 million, ending what...To view the full article, register now.
Already a subscriber? Click here to view full article